Tuangsit Wataganara - Gynecology

Author Information

Dr. Tuangsit Wataganara is affiliated with the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. His work primarily focuses on maternal and fetal medicine, with significant contributions to the field of obstetrics and gynecology.

Research Contributions

Dr. Tuangsit Wataganara has made substantial contributions to the field of maternal and fetal medicine. His research encompasses a wide range of topics including fetal therapy, preeclampsia prediction, fetal Doppler studies, and the impact of COVID-19 on obstetric practices. Notably, his recent work involves the ablative effect of interstitial laser settings in human placental models and the teaching of percutaneous fetoscopic myelomeningocele repair. His studies have significantly advanced our understanding of prenatal screening, fetal therapy, and the management of severe hypertension in pregnancy.

Aliases

Dr. Tuangsit Wataganara is also known by the following aliases: T Wataganara, T. Wataganara, and Tuangsit Wataganara.

Publication and Citation Metrics

Metric	Value
Citation Count	1306
H-index	19
Paper Count	117

Publications:

Ablative effect of the interstitial laser setting in the human placental model

DOI: 10.1111/jog.15190

Year: 2022

Teaching and training the total percutaneous fetoscopic myelomeningocele repair

DOI: 10.1515/jpm-2020-0591

Year: 2021

‘Getting to zero’ cross transmission of SARS-CoV-2 in obstetric ultrasound during COVID-19 pandemic

DOI: 10.1515/jpm-2020-0579

Year: 2021

Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11–13 Weeks’ Gestation

DOI: 10.1161/HYPERTENSIONAHA.121.18021

Year: 2021

VP37.13: Longitudinal study of uterine artery Doppler indices throughout gestation in women with and without previous Caesarean delivery

DOI: 10.1002/uog.24561

Year: 2021

From non-invasive to invasive fetal therapy: A comprehensive review and current update.

DOI: 10.1016/j.tjog.2021.05.004

Year: 2021

VP37.17: Maternal serum soluble fms‐like tyrosine kinase‐1 at 11–14 weeks of gestation in screening for pre‐eclampsia

DOI: 10.1002/uog.24565

Year: 2021

Reference values for fetal Doppler-based cardiocirculatory indices in monochorionic-diamniotic twin pregnancy

DOI: 10.1186/s12884-021-04255-w

Year: 2021

A 10-Year Retrospective Review of Prenatal Applications, Current Challenges and Future Prospects of Three-Dimensional Sonoangiography

DOI: 10.3390/diagnostics11081511

Year: 2021

Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women

DOI: 10.1002/jcph.1685

Year: 2020

What Are the Available Resources for Women to Quit Smoking?

What is Justice in Gynecology?

How is CRL Measured?

When is PT Testing Recommended in Gynecology?

Why is Detoxification Important for Reproductive Health?

Are there any complications associated with E. coli infections?

What Causes Heavy Bleeding?

What is Laser Vaginal Rejuvenation?

What is a Biophysical Profile (BPP)?

What is Gabapentin?

Partnered Content Networks

Relevant Topics